ArticleStroke2017

Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Mira Katan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.